Brief: Perrigo Announces U.S. FDA Approval For Opill OTC Daily Oral Contraceptive
July 13 (Reuters) - Perrigo Company PLC PRGO.N :
* PERRIGO ANNOUNCES U.S. FDA APPROVAL FOR OPILL® OTC DAILY
ORAL
CONTRACEPTIVE
* PERRIGO COMPANY PLC - OPILL WILL BE AVAILABLE IN STORE AND
ONLINE ACROSS U.S. EARLY IN Q1 OF 2024
Source text for Eikon: ID:nPnxxv80a
Further company coverage: PRGO.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Perrigo
See all newsPerrigo to pay $10 million to settle US class action over baby formula prices
Perrigo Company PLC reports results for the quarter ended June 30 - Earnings Summary
Brief: Perrigo Company Reaffirms Full-Year 2026 Outlook
Ireland's Perrigo Q2 profit beats on portfolio streamlining
Brief: Perrigo Company - Declares QTRLY Dividend Of $0.29 Per Share